Who owns HOBERMAN KENNETH?

No ownership or control links for HOBERMAN KENNETH are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is HOBERMAN KENNETH's risk level?

WhiteIntel flags HOBERMAN KENNETH as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does HOBERMAN KENNETH appear across sources?

HOBERMAN KENNETH is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

■

HOBERMAN KENNETH

Name: HOBERMAN KENNETH — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, HOBERMAN KENNETH, Company, US

Low

CompanyUS

View network JSON / MCPsample

Fig. 01 — Cross-source signature

/01

At a glance

Dimensions on file

Subsidiaries: 3

/02

Key facts

Risk signal

Low

Risk

HOBERMAN KENNETH is a Company registered in US resolved across 1 source in the WhiteIntel corporate-ownership graph.

/03

Ownership & control

Owners / controllers

None in current sources.

Holdings / subsidiaries

HOBERMAN KENNETH
- Nuvectis Pharma, Inc.· director· via SEC EDGAR
- TG THERAPEUTICS, INC.· director· via SEC EDGAR
- STEMLINE THERAPEUTICS INC· officer· via SEC EDGAR

/04

Directorship network

67 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

Nuvectis Pharma, Inc.

TG THERAPEUTICS, INC.

HUME DANIELdirector
Charney Laurence Ndirector
WEISS MICHAEL Sofficer
Power Sean Aofficer
Power Sean Aofficer
HERSKOWITZ NEILdirector
WEISER MICHAELdirector
MCINERNEY TIMOTHYdirector
HARRIS ALAN Gofficer
HUME DANIELdirector
Charney Laurence Ndirector
LONIAL SAGARdirector
ECHELARD YANNdirector
Power Sean Aofficer
WEISS MICHAEL Sdirector
WEISS MICHAEL Sofficer
Shah Rajeev M.tenpercentowner
RA CAPITAL MANAGEMENT, L.P.tenpercentowner
Kolchinsky Petertenpercentowner
KENNEDY WILLIAM JAMESdirector
RA Capital Healthcare Fund LPtenpercentowner
SCHOENEBAUM MARKdirector
WEISS MICHAEL Stenpercentowner
LFB BIOTECHNOLOGIES S.A.S.U.tenpercentowner
OPUS POINT PARTNERS, LLCtenpercentowner
ABEL DOUGLASdirector
MORVILLE MALCOLMdirector
Steinhart Richard Idirector
WEISER MICHAELother
SHIMKO DAVIDdirector
Hoenlein Malcolmother
MCGUINNESS MICHAELofficer
ABEL DOUGLASofficer
Hoenlein Malcolmdirector
NORDIC BIOTECH VENTURE FUND II K/Stenpercentowner
GIMBERT JOAN PONSdirector

STEMLINE THERAPEUTICS INC

FRANCOMANO ROBERTofficer
HUME DANIELdirector
BERGSTEIN IVANdirector
FORMAN ALAN Sdirector
BENTSUR RONdirector
GIONCO DAVIDofficer
CLINE DARREN Sdirector
SARD MARKdirector
ZUERBLIS KENNETH Jdirector
BERGSTEIN IVANofficer
DOBMEIER ERICdirector
BERGSTEIN IVANtenpercentowner
BUCHI J KEVINdirector
ROWINSKY ERIC Kofficer
HALL STEPHEN Pofficer

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on HOBERMAN KENNETH. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnakeScore.

Loading tips…